Biotechnology
Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility
LAVAL, France, Sept. 4, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space. The expansion integrates Porsolt's new areas of...
2019-09-04 00:03
2369
Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe
BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com
2019-09-03 14:00
3084
International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk
MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...
2019-09-03 07:44
3351
Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China
- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...
2019-08-30 22:28
2678
DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds
NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...
2019-08-30 01:59
3296
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India
WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...
2019-08-29 20:04
2790
Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies
SINGAPORE, Aug. 29, 2019 /PRNewswire/ -- Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of ProfessorsMinh Le and Jiahai Shi at the CityUniversity of Hong Kong. Carmine Therape...
2019-08-29 11:00
2226
Innovent Reports Interim Results for Fiscal Year 2019
SUZHOU, China, Aug. 29, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months endedJune 30, 2019. HIGHLIGHTS AND OTH...
2019-08-29 08:39
3468
Ascletis Received IND Approval for its NASH Drug
HANGZHOU, China and SHAOXING, China, Aug. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that toget...
2019-08-28 08:00
4124
LBB Specialties Announces Strategic Partnership With MEGGLE On US Distribution Of Excipient Products
NORWALK, Connecticut, Aug. 28, 2019 /PRNewswire/ -- LBB Specialties announced that effectiveAugust 1, 2019, LBB has entered into a strategic partnership with MEGGLE Excipients & Technology to distribute MEGGLE's excipient products to companies in the American pharmaceutical and nutraceutical indu...
2019-08-28 06:00
2055
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
2019-08-28 04:16
8414
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
2019-08-28 04:16
9195
Origin Agritech Entered Collaboration Agreement with Biotechnology Research Institute of Chinese Academy of Agriculture Sciences to Speed up Commercialization of GM Traits in China
BEIJING, Aug. 27, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Biotechnology Research Institute (BRI) of Chinese Academ...
2019-08-27 20:00
4436
DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration
SALT LAKE CITY, Aug. 27, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that the U.S. Food and Drug ...
2019-08-27 07:00
2210
Atonarp Inc. Announces $33 Million Series C Funding Round Completion
- Financing round brings five new investors to Atonarp, including Japan Post Investment Corporation and SBI Investment Co., Ltd. - Series C was oversubscribed as investor demand was driven by the company's accelerating development progress of disruptive healthcare diagnostics platform. - Fundin...
2019-08-26 07:00
2887
Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX
SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study onFrontiers in Oncology comparing GenesWell(TM) BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cance...
2019-08-23 08:00
2809
Voronoi selects CDD Vault platform to manage its Drug Discovery Data
INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collabora...
2019-08-23 06:36
4440
Biotech Conagen Acquires Production Platform of Therapeutic Proteins
The technology should reduce costs to patients and accelerate drug development BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...
2019-08-22 01:39
2809
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody
* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...
2019-08-21 21:35
4686
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results
HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close. The Company will host a conference call at 8:00 a.m....
2019-08-21 19:00
7674
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 317 media titles]
2024-06-25 21:00
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15576
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13163
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9412
